N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141175 |
| CAS No | NA |
| Mol.F. | C15H19N7O3 |
| Mol.Wt. | 345.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141176 |
| CAS No | NA |
| Mol.F. | C16H12BrN7O3 |
| Mol.Wt. | 430.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141177 |
| CAS No | NA |
| Mol.F. | C16H13N7O3 |
| Mol.Wt. | 351.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141178 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141179 |
| CAS No | NA |
| Mol.F. | C24H25N9O3 |
| Mol.Wt. | 487.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141180 |
| CAS No | NA |
| Mol.F. | C30H35N9O5 |
| Mol.Wt. | 601.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141181 |
| CAS No | NA |
| Mol.F. | C18H29N3O2 |
| Mol.Wt. | 319.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141182 |
| CAS No | 36966-84-4 |
| Mol.F. | C6H6N2O |
| Mol.Wt. | 122.1 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141183 |
| CAS No | NA |
| Mol.F. | C9H14N2OS |
| Mol.Wt. | 198.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141184 |
| CAS No | 70890-80-1 |
| Mol.F. | C2H2N4O2 |
| Mol.Wt. | 114.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141185 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141186 |
| CAS No | NA |
| Mol.F. | C18H16N2O3 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141187 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141188 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141189 |
| CAS No | NA |
| Mol.F. | C14H11N3O3 |
| Mol.Wt. | 269.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141190 |
| CAS No | NA |
| Mol.F. | C14H10N4O5 |
| Mol.Wt. | 314.3 |
| INV STATUS | CUSTOM SYNTHESIS |